Alumis Inc
Clinical trials sponsored by Alumis Inc, explained in plain language.
-
First human test: how kidneys process experimental drug
Knowledge-focused CompletedThis early-stage study tested how kidney function affects how the body processes ESK-001, an experimental oral drug. Researchers gave a single dose to 16 participants with varying levels of kidney function and healthy volunteers. The main goal was to measure drug levels in the bl…
Phase: PHASE1 • Sponsor: Alumis Inc • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
First human test of new pill checks for safety
Knowledge-focused CompletedThis was the first study in people to test a new oral drug called A-005. It aimed to see if the drug is safe, what side effects it might cause, and how the body absorbs and processes it. The study involved 135 healthy adult volunteers who took either the drug or a placebo. A smal…
Phase: PHASE1 • Sponsor: Alumis Inc • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC
-
First human test: does new drug affect the heart?
Knowledge-focused CompletedThis early-stage study tested a new drug called ESK-001 in 52 healthy people. The main goal was to see if the drug affects heart rhythm and to measure how the body absorbs and processes it. Researchers compared ESK-001 to a dummy pill (placebo) and a known antibiotic to check for…
Phase: PHASE1 • Sponsor: Alumis Inc • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC